HOME > ARCHIVE

ARCHIVE

Korosho's FY2003 Budget Request Totals \19,523.7 Bil., Up 4.58%

September 9, 2002
Drug Industry Vision Finalized

September 9, 2002
Telmisartan, Brinzolamide Recommended for Approval

September 9, 2002
PAL Amendment Discussed: Jiho Seminar -2-

September 9, 2002
PAL Amendment Discussed: Jiho Seminar

September 9, 2002
JAPANESE LANGUAGE BOOKS

September 9, 2002
WORLD NEWS IN BRIEF

September 9, 2002
MEDICAL DEVICE NEWS IN BRIEF

September 9, 2002
Website News

September 9, 2002
DIAGNOSTIC NEWS IN BRIEF

September 9, 2002
BULLETIN

September 9, 2002
< Advertisement >

September 9, 2002
10 Wholesalers Have 108 Returns of Damaged Goods in 1 Year

September 9, 2002
OTC NEWS IN BRIEF

September 9, 2002
Hiring of New Graduates by Wholesalers Remains at Low Level: PJ Survey

September 9, 2002
CORPORATE ROUNDUP NEWS IN BRIEF

September 9, 2002
AstraZeneca Hires Largest Number of New Graduates in 2002: PJ Survey

September 9, 2002
NEW PRODUCTS

September 9, 2002
Hitachi High-Tech to Market bioMerieux's Blood Coagulation Products

September 2, 2002
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

September 2, 2002

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Beyond Elevidys: Next-Generation DMD Therapies Advance through Multiple Approaches

By Shinya Sato

The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…